These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 6213126)

  • 1. [Effect of acute administration of verapamil on various metabolic parameters in healthy humans].
    Orlandini G; Bonetti A; Zuliani U
    Acta Biomed Ateneo Parmense; 1982; 53(2):65-8. PubMed ID: 6213126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute administration of calcium antagonists: effects on various parameters of glyco-lipid metabolism].
    Bonetti A; Campana M; Cerioli GC; Solito F; Tirelli F; Zuliani U
    G Clin Med; 1987 May; 68(5):289-92. PubMed ID: 3305123
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of galactose, glucose and fructose on carbohydrate-lipid metabolism.
    Manso JM; Jover E; Mayor F; Velasco R; Romero H
    J Med; 1979; 10(6):479-86. PubMed ID: 400743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of an infusion of glucose-insulin-potassium and of heparin on the plasma free fatty acid levels and on blood glucose].
    Haslauer F; Krempler F; Bolzano K; Sandhofer F
    Wien Klin Wochenschr; 1983 Sep; 95(17):618-21. PubMed ID: 6359725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of insulin and epinephrine in human metabolism: their influence on carbohydrate and lipid oxidation rate.
    Müller-Hess R; Geser CA; Pittet P; Chappuis P; Jéquier E; Felber JP
    Diabete Metab; 1975 Sep; 1(3):151-7. PubMed ID: 1234578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential metabolic responses to tumor necrosis factor with increase in age.
    Mondon CE; Starnes HF
    Metabolism; 1992 Sep; 41(9):970-81. PubMed ID: 1518426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of verapamil in man.
    Koike Y; Shimamura K; Shudo I; Saito H
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):37-47. PubMed ID: 432439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metabolic intervention on substrate metabolism in the human heart.
    Kaijser L
    Adv Myocardiol; 1980; 2():51-9. PubMed ID: 7423062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose lowering effect of verapamil in fasted man.
    Andersson DE; Röjdmark S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():160-3. PubMed ID: 6398256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
    van Baak MA; Böhm RO; Petri J; Rahn KH
    Int J Sports Med; 1987 Aug; 8(4):270-4. PubMed ID: 3667024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Acta Med Scand; 1982; 211(1-2):35-43. PubMed ID: 7041521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ketonaemia in hyperthyroidism: study of the role of free fatty acids.
    Beylot M; Cohen R; Riou JP; Sautot G; Garcia I; Noel G; Mornex R
    Diabete Metab; 1983 Sep; 9(3):217-23. PubMed ID: 6360743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of butylbiguanide during long lasting intravenous glucose infusion in normal human subjects.
    Gomez F; Felber JP
    Horm Metab Res; 1970 Mar; 2(2):72-5. PubMed ID: 5520911
    [No Abstract]   [Full Text] [Related]  

  • 17. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
    Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
    Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both.
    Osman MA; Allen PS; Mehyar NA; Bobe G; Coetzee JF; Koehler KJ; Beitz DC
    J Dairy Sci; 2008 Sep; 91(9):3311-22. PubMed ID: 18765590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamil.
    Berk SI; Beckman K; Hoon TJ; Hariman RJ; Hu D; Siegel FP; Bauman JL
    Pharmacotherapy; 1992; 12(1):33-9. PubMed ID: 1549537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.